Last reviewed · How we verify
NCT05570474: PROMISE
Effect of Protein Supplementation on Fat Free Mass Preservation After Bariatric Surgery
NA trial testing Protein drink supplementation in Bariatric Surgery Candidate in 266 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | Maasstad Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 266 |
| Start date | 1 September 2022 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Protein drink supplementation
- Placebo
Conditions studied
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
- Protein Deficiency — all drugs for Protein Deficiency →
- Muscle Loss — all drugs for Muscle Loss →
Sponsor
Maasstad Hospital
Who can join
Adults 18 to 65, any sex, with Bariatric Surgery Candidate or Protein Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This double blind randomized placebo controlled trial investigates the effect of protein supplementation on fat free mass loss in patients who underwent a Roux-en-Y gastric bypass.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
PROMISE: effect of protein supplementation on fat-free mass preservation after bariatric surgery, a randomized double-blind placebo-controlled trial.
Taselaar AE, Boes AJ, de Bruin RWF, Kuijper TM, et al · · 2023 · cited 3× · PMID 37946272 · DOI 10.1186/s13063-023-07654-w
Verify or expand the search:
- PubMed search for NCT05570474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bariatric Surgery Candidate
Currently open trials in the same condition.
- NCT07525232 — Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients · NA · recruiting
- NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
- NCT05966727 — Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients · NA · recruiting
- NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
Other Maasstad Hospital trials
Trials by the same sponsor.
- NCT05507983 — Tranexamic Acid During Excisional Burn Surgery · Phase 3 · unknown
- NCT04755127 — Arthroscopic Synovectomy of the Wrist in Inflammatory Arthritis · NA · unknown
- NCT05037916 — Comparison of Laser Speckle Contrast Imaging and Laser Doppler Imaging in Burn Patients · completed
- NCT04660162 — Comparison of Laser Speckle Contrast Imaging and Laser Doppler Imaging · NA · completed
- NCT04500197 — A Study of MIcrocirculatory Perfusion Alterations in Severe Burn Injury · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05570474 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maasstad Hospital
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05570474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing